Загрузка...
Intravitreal bevacizumab as an adjunct in the management of a vascular choroidal granuloma
A 43-year-old woman with tubercular choroidal granuloma showed poor response to conventional first-line four-drug antitubercular therapy (ATT) and corticosteroids. A therapeutic trial with intravitreal bevacizumab (1.25 mg in 0.05 mL) injections as an adjunct to ATT and corticosteroids led to a prom...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMJ Publishing Group
2013
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3794147/ https://ncbi.nlm.nih.gov/pubmed/24014333 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2013-200255 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|